We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on the development and commercialization of therapies for people living with rare diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomer... Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on the development and commercialization of therapies for people living with rare diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN) - rare kidney disorders that often lead to end-stage kidney disease. Show more
SAN DIEGO, May 15, 2024 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that on May 10, 2024, the Compensation Committee of its Board of Directors granted...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.6 | -9.00900900901 | 6.66 | 7.19 | 6.025 | 968458 | 6.5798612 | CS |
4 | 0.33 | 5.75916230366 | 5.73 | 7.69 | 5.12 | 1334900 | 6.0551086 | CS |
12 | -2.09 | -25.6441717791 | 8.15 | 9.03 | 5.12 | 1238854 | 6.90788175 | CS |
26 | -0.03 | -0.492610837438 | 6.09 | 10.27 | 5.12 | 1355853 | 7.7072331 | CS |
52 | -10.47 | -63.3393829401 | 16.53 | 19.5424 | 5.12 | 1406675 | 9.71382254 | CS |
156 | -12.15 | -66.7215815486 | 18.21 | 31.65 | 5.12 | 1094944 | 16.68037507 | CS |
260 | -19.09 | -75.9045725646 | 25.15 | 33.0899 | 5.12 | 1019301 | 17.391575 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions